Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression.
- Author:
Tianyue LIU
1
;
Chenying HAN
1
;
Chenchen HU
1
;
Siyi MAO
2
;
Yuanjie SUN
1
;
Shuya YANG
3
;
Kun YANG
4
Author Information
1. Department of Immunology, Basic Medical Science Academy, Air Force Medical University, Xi'an 710032, China.
2. The Fourth Regiment, Basic Medical Science Academy, Air Force Medical University, Xi'an 710032, China.
3. Department of Immunology, Basic Medical Science Academy, Air Force Medical University, Xi'an 710032, China. *Corresponding authors, E-mail: yangshuxiaoya@163.com.
4. Department of Immunology, Basic Medical Science Academy, Air Force Medical University, Xi'an 710032, China. *Corresponding authors, E-mail: yangkunkun@fmmu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Humans;
Cell Line, Tumor;
Cell Movement/genetics*;
Cell Proliferation/genetics*;
Colorectal Neoplasms/metabolism*;
Gene Expression Regulation, Neoplastic;
Interleukin-10/metabolism*;
RNA, Messenger;
RNA-Binding Proteins/metabolism*;
Transforming Growth Factor beta/genetics*;
Tumor Microenvironment/immunology*;
Tumor Necrosis Factor-alpha/metabolism*;
Proto-Oncogene Proteins c-myc/metabolism*
- From:
Chinese Journal of Cellular and Molecular Immunology
2023;39(4):303-310
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) on the proliferation, migration and tumor immune microenvironment of colorectal cancer cells and its possible molecular mechanism. Methods The Cancer Genome Atlas (TCGA) database was used to analyze the expression levels of IGF2BP2 and MYC in colorectal cancer and adjacent tissues. The expression of IGF2BP2 in HCT-116 and SW480 human colorectal cancer cells was silenced by RNA interference (RNAi), and the silencing effect was detected by quantitative real-time PCR. After knocking down IGF2BP2, colony formation assay, CCK-8 assay and 5-ethynyl-2'-deoxyuridine (EdU) assay were employed to detect cell colony formation and proliferation ability. TranswellTM assay was used to detect cell migration ability. Quantitative real-time PCR was used to detect the mRNA expression of IGF2BP2, MYC, tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and interleukin-10 (IL-10). The protein expression of IGF2BP2 and MYC was detected by western blot. The binding ability of IGF2BP2 and MYC in HCT-116 cells was detected by quantitative real-time PCR after RNA immunoprecipitation. Results The results of TCGA database showed that the expression of IGF2BP2 and MYC in colorectal cancer tissues was significantly higher than that in adjacent tissues, and the survival time of colorectal cancer patients with high expression of IGF2BP2 was shorter. After silencing IGF2BP2, the viability, proliferation and migration of HCT-116 and SW480 cells were decreased. The mRNA expression of MYC, TGF-β and IL-10 in IGF2BP2 knockdown group was significantly decreased, while the expression of TNF-α mRNA was increased. The expression of MYC protein and the stability of MYC mRNA were significantly decreased. RIP-qPCR results showed that IGF2BP2 could bind to MYC mRNA. Conclusion Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression.
